Literature DB >> 8162571

Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice.

J Bezault1, R Bhimani, J Wiprovnick, P Furmanski.   

Abstract

The antitumor effects of the multifunctional iron-binding glycoprotein, lactoferrin (Lf), were investigated. Lf inhibited growth in mice of transplantable solid tumors induced by v-ras transformed fibroblasts and a methylcholanthrene-induced fibrosarcoma. Lf also substantially reduced lung colonization (experimental metastasis) by B16-F10 melanoma cells in syngeneic mice. Iron-saturated and apo-Lf exhibited comparable levels of tumor inhibition and antimetastatic activity. Transferrin, a related iron-binding protein, had no effect on lung colonization. In the B16-F10 system, elimination of natural killer cell activity by pretreatment of mice with anti-asialo GM1 antibody abrogated the effects of Lf, whereas inhibition of macrophage function with silica did not. The results demonstrate a novel activity for Lf and suggest a potentially important role for this molecule in the primary defense against tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162571

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.

Authors:  Y Yang; M Kost-Alimova; S Ingvarsson; Q Qianhui; H Kiss; A Szeles; I Kholodnyuk; A Cuthbert; G Klein; S Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

3.  Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice.

Authors:  M Iigo; T Kuhara; Y Ushida; K Sekine; M A Moore; H Tsuda
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

4.  Lactoferrin Expression in Human and Murine Ocular Tissue.

Authors:  Abrar A Rageh; Deborah A Ferrington; Heidi Roehrich; Ching Yuan; Marcia R Terluk; Elizabeth F Nelson; Sandra R Montezuma
Journal:  Curr Eye Res       Date:  2015-10-02       Impact factor: 2.424

Review 5.  The role of talactoferrin alpha in the treatment of non-small cell lung cancer.

Authors:  Ronan J Kelly; Giuseppe Giaccone
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

Review 6.  Networking galore: intermediate filaments and cell migration.

Authors:  Byung-Min Chung; Jeremy D Rotty; Pierre A Coulombe
Journal:  Curr Opin Cell Biol       Date:  2013-07-22       Impact factor: 8.382

7.  Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer.

Authors:  Gengqiu Luo; Yanhong Zhou; Wei Yi; Hong Yi
Journal:  Oncol Lett       Date:  2015-03-03       Impact factor: 2.967

8.  Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo.

Authors:  Jeffrey S Wolf; Guoyan Li; Atul Varadhachary; Karel Petrak; Mark Schneyer; Daqing Li; Julina Ongkasuwan; Xiaoyu Zhang; Rodney J Taylor; Scott E Strome; Bert W O'Malley
Journal:  Clin Cancer Res       Date:  2007-03-01       Impact factor: 12.531

9.  miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Authors:  Min Deng; Qiurong Ye; Zailong Qin; Ying Zheng; Wei He; Hailin Tang; Yanhong Zhou; Wei Xiong; Ming Zhou; Xiaoling Li; Qun Yan; Jian Ma; Guiyuan Li
Journal:  Tumour Biol       Date:  2013-03-13

10.  Gene expression profiling of peripheral blood cells for early detection of breast cancer.

Authors:  Jørgen Aarøe; Torbjørn Lindahl; Vanessa Dumeaux; Solve Saebø; Derek Tobin; Nina Hagen; Per Skaane; Anders Lönneborg; Praveen Sharma; Anne-Lise Børresen-Dale
Journal:  Breast Cancer Res       Date:  2010-01-15       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.